A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients.
Haitao JiangLianhe ZhaoYunjie ChenLiang SunPublished in: Journal of clinical laboratory analysis (2020)
The four-lncRNA signature can be used as an independent biomarker for HCC patients to predict the prognostic risk.